Detection of a case of chronic myeloid leukaemia with deletions at the t (9; 22) translocation breakpoints by a genome‐wide non‐invasive prenatal test
K Janssens, K Deiteren, A Verlinden… - Prenatal …, 2016 - Wiley Online Library
Objective Non‐invasive prenatal tests (NIPTs) interrogating the complete genome are able
to detect not only fetal trisomy 13, 18 or 21 but additionally provide information on other …
to detect not only fetal trisomy 13, 18 or 21 but additionally provide information on other …
Early landmark analysis of imatinib treatment in CML chronic phase: Less than 10% BCR‐ABL by FISH at 3 months associated with improved long‐term clinical …
L Ohm, I Arvidsson, G Barbany, R Hast… - American journal of …, 2012 - Wiley Online Library
Imatinib has dramatically improved the clinical outcome in chronic myeloid leukemia,
chronic phase (CMLcp), but a risk of resistance and serious disease progression still …
chronic phase (CMLcp), but a risk of resistance and serious disease progression still …
[HTML][HTML] Chronic myeloid leukemia with insertion-derived BCR–ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype …
Chromosomal insertion-derived BCR–ABL1 fusion is rare and mostly cryptic in chronic
myeloid leukemia (CML). Most of these cases present a normal karyotype, and their risk …
myeloid leukemia (CML). Most of these cases present a normal karyotype, and their risk …
Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia …
VS Nadarajan, CL Phan, CH Ang, KL Liang… - International journal of …, 2011 - Springer
The outcome of treating chronic myeloid leukemia (CML) with imatinib mesylate (IM) is
inferior when therapy is commenced in late chronic or accelerated phase as compared to …
inferior when therapy is commenced in late chronic or accelerated phase as compared to …
Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der (9) deletion, but does not …
J Huh, CW Jung, JW Kim, HJ Kim, SH Kim, MG Shin… - Annals of …, 2011 - Springer
The current study investigated molecular cytogenetic characteristics of chronic myeloid
leukemia (CML) using genome-wide, single nucleotide polymorphism arrays (SNP-A) …
leukemia (CML) using genome-wide, single nucleotide polymorphism arrays (SNP-A) …
[PDF][PDF] Молекулярная и цитогенетическая характеристика Ph-позитивного клона у больных хроническим миелолейкозом при длительном воздействии …
ОА Шухов - 2015 - blood.ru
Основным молекулярно-генетическим событием, приводящим к лейкемической
трансформации стволовых клеток и развитию хронического миелолекоза (ХМЛ) …
трансформации стволовых клеток и развитию хронического миелолекоза (ХМЛ) …
Prognostic implications of derivative chromosome 9 deletions in patients with advanced-stage chronic myelogenous leukemia
RK Chandran, N Geetha, KM Sakthivel… - Journal of …, 2018 - dl.begellhouse.com
Elucidation of cryptic BCR/ABL1 gene rearrangement is exceptionally important in the
clinical diagnosis and prognosis of chronic myelogenous leukemia (CML). Previous reports …
clinical diagnosis and prognosis of chronic myelogenous leukemia (CML). Previous reports …
[HTML][HTML] Chronic myeloid leukemia
UM Martens, J Loke, SH Faderl, M Dreyling, A Engert… - 1993 - everand.com
This book provides state-of-the-art reviews of key issues and recent developments relating
to chronic myeloid leukemia (CML), acquainting the reader with advances in research …
to chronic myeloid leukemia (CML), acquainting the reader with advances in research …
Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on …
J Huh, CW Jung, HJ Kim, YK Kim… - Genes …, 2013 - Wiley Online Library
The purpose of this study was to evaluate the detection rate of chromosomal
rearrangements in leukemia using single nucleotide polymorphism array (SNP‐A) in …
rearrangements in leukemia using single nucleotide polymorphism array (SNP‐A) in …